Extracellular protein disulfide isomerase (PDI) is a
promising
target for thrombotic-related diseases. Four potent PDI inhibitors
with unprecedented chemical architectures, piericones A–D (1–4), were isolated from Pieris japonica. Their structures were elucidated by spectroscopic data analysis,
chemical methods, quantum 13C nuclear magnetic resonance
DP4+ and electronic circular dichroism calculations, and single-crystal
X-ray diffraction analysis. Piericones A (1) and B (2) were nanomolar noncompetitive PDI inhibitors possessing
an unprecedented 3,6,10,15-tetraoxatetracyclo[7.6.0.04,9.01,12]pentadecane motif with nine contiguous stereogenic
centers. Their biosynthetic pathways were proposed to include a key
intermolecular aldol reaction and an intramolecular 1,2-migration
reaction. Piericone A (1) significantly inhibited in
vitro platelet aggregation and fibrin formation and in vivo thrombus
formation via the inhibition of extracellular PDI without increasing
the bleeding risk. The molecular docking and dynamics simulation of 1 and 2 provided a novel structure basis to develop
PDI inhibitors as potent antithrombotics.